FIELD: medicine.
SUBSTANCE: invention refers to medical devices, particularly to drug delivery devices. The device comprises an expandable element having an external surface contacting surrounding tissue. A liquid formulation of a therapeutically active substance is connected to the external surface. The liquid formulation contains rapamycin in a pharmacologically effective dosage, ethanol in a trough concentration of approximately 1.57 mass percent, vitamin E TPGS in an amount of approximately 6.55 mass percent and water in an amount of approximately 90.51 mass percent. The liquid formulation contains a finishing solution of rapamycin in a span of concentrations from approximately 4 mg/ml to approximately 15 mg/ml. The expandable element can represent, e.g. a stent.
EFFECT: device provides the local and regional delivery of the therapeutically active substances for inhibiting body reaction to introducing the device, thereby preventing thrombosis, treating restenosis, and atherosclerotic plaques in the patients suffering diabetes mellitus.
6 cl, 111 dwg, 23 tbl
Title | Year | Author | Number |
---|---|---|---|
LOCAL VASCULAR DELIVERY OF PROBUCOL, ALONE OR IN COMBINATION WITH SIROLIMUS, FOR TREATMENT OF RESTENOSIS, VULNERABLE PLAQUES, AAA (ABDOMINAL AORTA ANEURISM) AND STROKE | 2008 |
|
RU2481084C2 |
DEVICE FOR LOCAL AND/OR REGIONAL DELIVERY USING LIQUID FORMULATIONS OF THERAPEUTICALLY ACTIVE SUBSTANCES | 2009 |
|
RU2596092C2 |
LOCAL VASCULAR DELIVERY OF mTOR INHIBITORS IN COMBINATION WITH PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR STIMULATORS | 2008 |
|
RU2510654C2 |
RAPAMICIN-RELEASING STENT | 2010 |
|
RU2563429C2 |
STENT WITH DOUBLE DRUG RELEASE | 2010 |
|
RU2552086C2 |
LOCAL DELIVERY OF COMBINATION OF ADENOSINE A2A RECEPTOR AGONISTS/PHOSPHODIESTERASE INHIBITOR IN VESSELS TO RELIEVE MYOCARDIAL INVOLVEMENT SEVERITY | 2011 |
|
RU2565403C2 |
ELUTING STENT WITH CONTAINERS | 2010 |
|
RU2541753C2 |
BARE METAL STENT WITH MEDICATION-RELEASING RESERVOIRS | 2011 |
|
RU2573107C2 |
PRIMER-ADHESION PROMOTER FOR SURFACES WITH COATING | 2009 |
|
RU2522390C2 |
ENDOLUMINAL PROSTHESIS CONTAINING MEDICAL AGENT | 2004 |
|
RU2360646C2 |
Authors
Dates
2014-04-20—Published
2009-03-30—Filed